Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small internal update to the page's version. This change does not affect the study details or visible content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This reflects a metadata update to the study record on the page.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page. This update does not change any study details or visible content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a software/feature update of the page; the change does not modify the study details or displayed data.SummaryDifference0.0%

- Check74 days agoChange DetectedNew navigation/help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and a statement now indicates that the site is no longer looking for participants. The Intervention/Treatment heading formatting was adjusted, and the page's revision tag updated to v3.6.0 (replacing the previous v3.5.5).SummaryDifference0.2%

- Check81 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a small update to the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.